FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Congressional Dems Ask SCOTUS Mifepristone Reversal

More than 260 congressional Democrats ask the Supreme Court to reverse lower court rulings restricting the use of the medical abortion drug mifepristo...

Medical Devices

Respironics Reports 111 Deaths in 3Q 2023: FDA

Just two days after agreeing to a consent decree, FDA says that Philips Respironics reported over 7,000 medical device reports and 111 death reports f...

latest-news-card-1
Federal Register

Guide on Monoclonal Antibodies Docket Correction

Federal Register notice: FDA corrects a 12/21/2023 notice announcing the availability of a final guidance entitled Development of Monoclonal Antibody ...

Medical Devices

FDA to Down-classify Many IVDs

CDRH director Jeffrey Shuren says the Center will propose down-classifying many in vitro diagnostic tests from Class 3 to Class 2 in the hope of incre...

latest-news-card-1
Human Drugs

World Cancer Day Treatment Virtual Discussion

FDA and EMA schedule a 2/1 virtual public discussion on innovative therapies for some cancers to mark World Cancer Day.

latest-news-card-1
Human Drugs

Defender Pharma Complete Response on Nausea Drug

FDA sends Defender Pharmaceuticals a complete response letter on its NDA for intranasal scopolamine (DPI-386) for preventing nausea and vomiting induc...

latest-news-card-1
Medical Devices

Musk Reports Implanting 1st Chip in Human Brain

Neuralink founder Elon Musk announces the first chip implant in the brain of a human clinical trial participant.

latest-news-card-1
Federal Register

Panel to Discuss Geron Imetelstat NDA

Federal Register notice: FDA announces a 3/14 Oncologic Drugs Advisory Committee meeting to discuss a Geron NDA for imetelstat for injection.

latest-news-card-1
Federal Register

Guide on Genome Editing Gene Therapies

Federal Register notice: FDA makes available a final guidance entitled Human Gene Therapy Products Incorporating Human Genome Editing.

latest-news-card-1
Federal Register

Guide on CAR T Cell Product Development

Federal Register notice: FDA makes available a final guidance entitled Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Pr...